Expression of key hypoxia sensing prolyl-hydroxylases PHD1, -2 and -3 in pancreaticobiliary cancer.
AIMS: Tumour hypoxia is associated with an aggressive phenotype and resistance to chemotherapy and radiotherapy. The aim was to investigate whether key hypoxia sensing prolyl hydroxylases PHD1, PHD2 and PHD3 are dysregulated in pancreaticobiliary cancers, and to evaluate their potential clinical si...
主要な著者: | Gossage, L, Zaitoun, A, Fareed, K, Turley, H, Aloysius, M, Lobo, D, Harris, A, Madhusudan, S |
---|---|
フォーマット: | Journal article |
言語: | English |
出版事項: |
2010
|
類似資料
-
Differential function of the prolyl hydroxylases PHD1, PHD2, and PHD3 in the regulation of hypoxia-inducible factor.
著者:: Appelhoff, R, 等
出版事項: (2004) -
Hypoxia-inducible factor prolyl-hydroxylase: purification and assays of PHD2.
著者:: Hewitson, K, 等
出版事項: (2007) -
Cellular oxygen sensing: Crystal structure of hypoxia-inducible factor prolyl hydroxylase (PHD2).
著者:: McDonough, M, 等
出版事項: (2006) -
The use of dioxygen by HIF prolyl hydroxylase (PHD1).
著者:: McNeill, L, 等
出版事項: (2002) -
Expression of prolyl-hydroxylases PHD-1, 2 and 3 and of the asparagine hydroxylase FIH in non-small cell lung cancer relates to an activated HIF pathway.
著者:: Giatromanolaki, A, 等
出版事項: (2008)